These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37368513)

  • 21. An individual patient data meta-analysis to determine cut-offs for and confounders of NAFLD-fibrosis staging with magnetic resonance elastography.
    Liang JX; Ampuero J; Niu H; Imajo K; Noureddin M; Behari J; Lee DH; Ehman RL; Rorsman F; Vessby J; Lacalle JR; Mózes FE; Pavlides M; Anstee QM; Harrison SA; Castell J; Loomba R; Romero-Gómez M;
    J Hepatol; 2023 Sep; 79(3):592-604. PubMed ID: 37121437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlations Between MRI Biomarkers PDFF and cT1 With Histopathological Features of Non-Alcoholic Steatohepatitis.
    Dennis A; Kelly MD; Fernandes C; Mouchti S; Fallowfield JA; Hirschfield G; Pavlides M; Harrison S; Chakravarthy MV; Banerjee R; Sanyal A
    Front Endocrinol (Lausanne); 2020; 11():575843. PubMed ID: 33584535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MRI-based (MAST) score accurately identifies patients with NASH and significant fibrosis.
    Noureddin M; Truong E; Gornbein JA; Saouaf R; Guindi M; Todo T; Noureddin N; Yang JD; Harrison SA; Alkhouri N
    J Hepatol; 2022 Apr; 76(4):781-787. PubMed ID: 34798176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MR elastography is effective for the non-invasive evaluation of fibrosis and necroinflammatory activity in patients with nonalcoholic fatty liver disease.
    Costa-Silva L; Ferolla SM; Lima AS; Vidigal PVT; Ferrari TCA
    Eur J Radiol; 2018 Jan; 98():82-89. PubMed ID: 29279175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MRI Assessment of Treatment Response in HIV-associated NAFLD: A Randomized Trial of a Stearoyl-Coenzyme-A-Desaturase-1 Inhibitor (ARRIVE Trial).
    Ajmera VH; Cachay E; Ramers C; Vodkin I; Bassirian S; Singh S; Mangla N; Bettencourt R; Aldous JL; Park D; Lee D; Blanchard J; Mamidipalli A; Boehringer A; Aslam S; Leinhard OD; Richards L; Sirlin C; Loomba R
    Hepatology; 2019 Nov; 70(5):1531-1545. PubMed ID: 31013363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utility and variability of three non-invasive liver fibrosis imaging modalities to evaluate efficacy of GR-MD-02 in subjects with NASH and bridging fibrosis during a phase-2 randomized clinical trial.
    Harrison SA; Dennis A; Fiore MM; Kelly MD; Kelly CJ; Paredes AH; Whitehead JM; Neubauer S; Traber PG; Banerjee R
    PLoS One; 2018; 13(9):e0203054. PubMed ID: 30192782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.
    Harrison SA; Bashir MR; Guy CD; Zhou R; Moylan CA; Frias JP; Alkhouri N; Bansal MB; Baum S; Neuschwander-Tetri BA; Taub R; Moussa SE
    Lancet; 2019 Nov; 394(10213):2012-2024. PubMed ID: 31727409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver fibrosis assessment: MR and US elastography.
    Ozturk A; Olson MC; Samir AE; Venkatesh SK
    Abdom Radiol (NY); 2022 Sep; 47(9):3037-3050. PubMed ID: 34687329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective Evaluation of Virtual MR Elastography With Diffusion-Weighted Imaging in Subjects With Nonalcoholic Fatty Liver Disease.
    Hanniman E; Costa AF; Bowen CV; Abdolell M; Stueck A; McLeod M; Peltekian K; Rioux J; Clarke SE
    J Magn Reson Imaging; 2022 Nov; 56(5):1448-1456. PubMed ID: 35285996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association Between Magnetic Resonance Imaging-Proton Density Fat Fraction and Liver Histology Features in Patients With Nonalcoholic Fatty Liver Disease or Nonalcoholic Steatohepatitis.
    Wildman-Tobriner B; Middleton MM; Moylan CA; Rossi S; Flores O; Chang ZA; Abdelmalek MF; Sirlin CB; Bashir MR
    Gastroenterology; 2018 Nov; 155(5):1428-1435.e2. PubMed ID: 30031769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver Investigation: Testing Marker Utility in Steatohepatitis (LITMUS): Assessment & validation of imaging modality performance across the NAFLD spectrum in a prospectively recruited cohort study (the LITMUS imaging study): Study protocol.
    Pavlides M; Mózes FE; Akhtar S; Wonders K; Cobbold J; Tunnicliffe EM; Allison M; Godfrey EM; Aithal GP; Francis S; Romero-Gomez M; Castell J; Fernandez-Lizaranzu I; Aller R; González RS; Agustin S; Pericàs JM; Boursier J; Aube C; Ratziu V; Wagner M; Petta S; Antonucci M; Bugianesi E; Faletti R; Miele L; Geier A; Schattenberg JM; Tilman E; Ekstedt M; Lundberg P; Berzigotti A; Huber AT; Papatheodoridis G; Yki-Järvinen H; Porthan K; Schneider MJ; Hockings P; Shumbayawonda E; Banerjee R; Pepin K; Kalutkiewicz M; Ehman RL; Trylesinksi A; Coxson HO; ; Martic M; Yunis C; Tuthill T; Bossuyt PM; Anstee QM; Neubauer S; Harrison S
    Contemp Clin Trials; 2023 Nov; 134():107352. PubMed ID: 37802221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Role of Three-Dimensional Magnetic Resonance Elastography in the Diagnosis of Nonalcoholic Steatohepatitis in Obese Patients Undergoing Bariatric Surgery.
    Allen AM; Shah VH; Therneau TM; Venkatesh SK; Mounajjed T; Larson JJ; Mara KC; Schulte PJ; Kellogg TA; Kendrick ML; McKenzie TJ; Greiner SM; Li J; Glaser KJ; Wells ML; Chen J; Ehman RL; Yin M
    Hepatology; 2020 Feb; 71(2):510-521. PubMed ID: 30582669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Automated Analysis of Multiparametric Magnetic Resonance Imaging/Magnetic Resonance Elastography Exams for Prediction of Nonalcoholic Steatohepatitis.
    Dzyubak B; Li J; Chen J; Mara KC; Therneau TM; Venkatesh SK; Ehman RL; Allen AM; Yin M
    J Magn Reson Imaging; 2021 Jul; 54(1):122-131. PubMed ID: 33586159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in abdominal adipose tissue depots assessed by MRI correlate with hepatic histologic improvement in non-alcoholic steatohepatitis.
    Shen W; Middleton MS; Cunha GM; Delgado TI; Wolfson T; Gamst A; Fowler KJ; Alazraki A; Trout AT; Ohliger MA; Shah SN; Bashir MR; Kleiner DE; Loomba R; Neuschwander-Tetri BA; Sanyal AJ; Zhou J; Sirlin CB; Lavine JE
    J Hepatol; 2023 Feb; 78(2):238-246. PubMed ID: 36368598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cilofexor, a Nonsteroidal FXR Agonist, in Patients With Noncirrhotic NASH: A Phase 2 Randomized Controlled Trial.
    Patel K; Harrison SA; Elkhashab M; Trotter JF; Herring R; Rojter SE; Kayali Z; Wong VW; Greenbloom S; Jayakumar S; Shiffman ML; Freilich B; Lawitz EJ; Gane EJ; Harting E; Xu J; Billin AN; Chung C; Djedjos CS; Subramanian GM; Myers RP; Middleton MS; Rinella M; Noureddin M
    Hepatology; 2020 Jul; 72(1):58-71. PubMed ID: 32115759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Magnetic resonance imaging for the assessment of pathological hepatic findings in nonalcoholic fatty liver disease.
    Imajo K; Honda Y; Yoneda M; Saito S; Nakajima A
    J Med Ultrason (2001); 2020 Oct; 47(4):535-548. PubMed ID: 33108553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease.
    Castera L; Friedrich-Rust M; Loomba R
    Gastroenterology; 2019 Apr; 156(5):1264-1281.e4. PubMed ID: 30660725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical implications of hepatic structure and function evaluation based on vibration-controlled transient elastography and liver maximum function capacity test in patients with nonalcoholic fatty liver disease.
    Blank V; Petroff D; Boehlig A; Heinze A; Karlas T; Berg T; Wiegand J
    Eur J Gastroenterol Hepatol; 2022 Jun; 34(6):686-692. PubMed ID: 35102112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver stiffness thresholds to predict disease progression and clinical outcomes in bridging fibrosis and cirrhosis.
    Loomba R; Huang DQ; Sanyal AJ; Anstee QM; Trauner M; Lawitz EJ; Ding D; Ma L; Jia C; Billin A; Huss RS; Chung C; Goodman Z; Wong VW; Okanoue T; Romero-Gómez M; Abdelmalek MF; Muir A; Afdhal N; Bosch J; Harrison S; Younossi ZM; Myers RP
    Gut; 2023 Mar; 72(3):581-589. PubMed ID: 36750244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MR elastography-based liver fibrosis correlates with liver events in nonalcoholic fatty liver patients: A multicenter study.
    Han MAT; Vipani A; Noureddin N; Ramirez K; Gornbein J; Saouaf R; Baniesh N; Cummings-John O; Okubote T; Setiawan VW; Rotman Y; Loomba R; Alkhouri N; Noureddin M
    Liver Int; 2020 Sep; 40(9):2242-2251. PubMed ID: 32652744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.